Top Markets
#1 Purr Purr +56.55%
#2 Pons Pons +53.28%
#3 Smilek to the Bank Smilek to the Bank +50.56%
#4 StonkBroker StonkBroker +30.71%
#5 Non-Playable Coin Non-Playable Coin +28.02%
#6 TENDIES TENDIES +26.79%
#7 Kinetiq Kinetiq +26.27%
#8 ApeX ApeX +25.71%
#9 Morpho Morpho +22.27%
#10 OriginTrail OriginTrail +21.30%
Coin of the day
Purr Purr
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Kinnate Biopharma Inc. Kinnate Biopharma Inc.

Kinnate Biopharma Inc.

KNTE
Clasificación en acciones #21072
Kinnate Biopharma Inc. is a U.S.-based biopharmaceutical company primarily... Kinnate Biopharma Inc. is a U.S.-based biopharmaceutical company primarily focused on identifying and advancing small-molecule drugs that target kinase enzymes to treat cancers defined by specific genetic markers. The company's product pipeline includes: KIN-2787: An inhibitor of rapidly accelerated fibrosarcoma (RAF), currently being developed to treat patients with lung cancer, melanoma, and other forms of solid tumors. KIN-3248: A small-molecule kinase inhibitor designed to counteract cancer-associated genetic mutations in the fibroblast growth factor receptors, specifically FGFR2 and FGFR3. KIN004 Program: This program encompasses early-stage small-molecule research, including a Cyclin-Dependent Kinase 12 (CDK12) inhibitor. Established in 2018, Kinnate Biopharma Inc. maintains its headquarters in San Francisco, California. It was formerly a division of Fount Therapeutics, LLC.
Precio por acción
$2.65
Última sincronización: 2024-04-03
Capitalización bursátil
$115.71M
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio Kinnate Biopharma Inc. (KNTE)

Categoría

Healthcare
Historial del precio de la acción de Kinnate Biopharma Inc. (KNTE)
Precio más alto de cierre: $2.65 el 2024-04-01

Precio más bajo de cierre: $40.13 el 2020-12-01
Historial del precio de la acción de Kinnate Biopharma Inc. desde 2020 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2024 15.54%
2023 -63.61%
2022 -64.96%
2021 -55.12%
2020 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $547.71 38.62%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.04K 58.06%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $145.75 437.43%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $118.70 -15.60%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $770.19 8.98%
CH